How much can investors make with Unitedhealth Group Inc (UNH) stock in the next 12 months?

At the time of writing, Unitedhealth Group Inc [UNH] stock is trading at $489.35, up 0.04%. An important factor to consider is whether the stock is rising or falling in short-term value. The UNH shares have gain 3.42% over the last week, with a monthly amount drifted -5.57%, and not seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

On 7, March 2024, UnitedHealth Group Update on Change Healthcare Cyberattack. In a post published today on Yahoo Finance, Timeline provided to restore key Change Healthcare systems.

From an analyst’s perspective:

Unitedhealth Group Inc [NYSE: UNH] stock has seen the most recent analyst activity on March 06, 2024, when Barclays initiated its Overweight rating and assigned the stock a price target of $551. Previously, HSBC Securities downgraded its rating to Reduce on December 18, 2023, and dropped its price target to $480. On October 16, 2023, upgrade upgraded it’s rating to Buy and revised its price target to $640 on the stock. HSBC Securities started tracking the stock assigning a Hold rating and suggested a price target of $540 on September 06, 2023. UBS reiterated its recommendation of a Neutral and raised its price target to $520 on July 19, 2023. Bernstein upgraded its rating to Outperform for this stock on July 18, 2023, and upped its price target to $603. In a note dated July 17, 2023, TD Cowen reiterated an Outperform rating on this stock and revised its target price from $562 to $555.

For the past year, the stock price of Unitedhealth Group Inc fluctuated between $445.68 and $554.70. Currently, Wall Street analysts expect the stock to reach $562.97 within the next 12 months. Unitedhealth Group Inc [NYSE: UNH] shares were valued at $489.35 at the most recent close of the market. An investor can expect a potential return of 15.04% based on the average UNH price forecast.

Analyzing the UNH fundamentals

According to Unitedhealth Group Inc [NYSE:UNH], the company’s sales were 371.62B for trailing twelve months, which represents an 14.06% jump. Gross Profit Margin for this corporation currently stands at -1.52% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at 0.08%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.25 and Total Capital is 0.18. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.72.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 487.04 points at the first support level, and at 484.72 for the second support level. However, for the 1st resistance point, the stock is sitting at 491.97, and for the 2nd resistance point, it is at 494.59.

Unitedhealth Group Inc [UNH] reported earnings per share of $6.16 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $5.98/share, meaning a difference of $0.18 and a surprise factor of 3.00%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $6.56 per share as compared to estimates of $6.32 per share, a difference of $0.24 representing a surprise of 3.80%.

Ratios To Look Out For

It is important to note that Unitedhealth Group Inc [NYSE:UNH] has a current ratio of 0.79. Considering the valuation of this stock, the price to sales ratio is 1.21, the price to book ratio is 5.09 and price to earnings (TTM) ratio is 20.52.

Transactions by insiders

Recent insider trading involved McSweeney Erin, EVP & Chief People Officer, that happened on Mar 08 ’24 when 1236.0 shares were sold. Chief Accounting Officer, ROOS THOMAS E completed a deal on Feb 23 ’24 to sell 858.0 shares. Meanwhile, CEO, UnitedHealthcare THOMPSON BRIAN R sold 28943.0 shares on Feb 16 ’24.

Related Posts